Aliskiren-containing medicinal products - Important Safety Information from Novartis Ireland as approved by the Irish Medicines Board
27 February 2012
Direct Healthcare Professional Communication on new contraindications and warnings for the use of aliskiren containing medicines in combination with angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs).
Aliskiren-containing medicinal products - Important Safety Information from Novartis Ireland as approved by the Irish Medicines Board